id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-N-0188-0076,FDA,FDA-2004-N-0188,Reference 9 Article 11.4.15 Bovine Spongiform Encephalopathy re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T16:55:14Z,,0,0,0900006481ecef4e
FDA-2004-N-0188-0067,FDA,FDA-2004-N-0188,Reference 1 BSE - A Decade On - Part I re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T16:36:06Z,,0,0,0900006481ecead0
FDA-2004-N-0188-0070,FDA,FDA-2004-N-0188,Reference 4 Confirmed Variant Creutzfeldt-Jakob Disease (variant CJD) Case in Texas re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T16:42:43Z,,0,0,0900006481ecead3
FDA-2004-N-0188-0091,FDA,FDA-2004-N-0188,Reference 24 Detection of disease-specific PrP in the distal ileum of cattle exposed orally to the agent of bovine spongiform encephalopathy re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T18:58:42Z,,0,0,0900006481ecec5a
FDA-2004-N-0188-0074,FDA,FDA-2004-N-0188,Reference 8 Inactivation of the BSE Agent by the Heat and Pressure Process for Manufacturing Gelatine re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T16:51:36Z,,0,0,0900006481ecef4c
FDA-2004-N-0188-0079,FDA,FDA-2004-N-0188,Reference 15 Article 11.4.14 Bovine Spongiform Encephalopathy re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T17:04:34Z,,0,0,0900006481ecec4b
FDA-2004-N-0188-0090,FDA,FDA-2004-N-0188,"Reference 23 BSE infectivity in jejunum, ileum and ileocaecal junction of incubating cattle re Use of Materials Derived From Cattle in Human Food and Cosmetics",Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T17:29:18Z,,0,0,0900006481ecec59
FDA-2004-N-0188-0083,FDA,FDA-2004-N-0188,Reference 16 BSE Ongoing Surveillance Plan final 71406 re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T17:12:50Z,,0,0,0900006481ecec4c
FDA-2004-N-0188-0088,FDA,FDA-2004-N-0188,Reference 21 Prevalence BSE (Bovine Spongiform Encephalopathy) re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T17:24:14Z,,0,0,0900006481ecec52
FDA-2004-N-0188-0099,FDA,FDA-2004-N-0188,Reference 28 vCJD Surveillance Data - CJD International Surveillance Network re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T19:14:05Z,,0,0,0900006481ecec5e
FDA-2004-N-0188-0073,FDA,FDA-2004-N-0188,Reference 7 Article 11.4.1 Bovine Spongiform Encephalopathy re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T16:49:11Z,,0,0,0900006481ecef4b
FDA-2004-N-0188-0065,FDA,FDA-2004-N-0188,Use of Materials Derived From Cattle in Human Food and Cosmetics,Rule,Final Rule,2016-03-18T04:00:00Z,2016,3,2016-03-18T04:00:00Z,,2016-03-25T16:28:15Z,2016-06123,0,0,0900006481ece21a
FDA-2004-N-0188-0069,FDA,FDA-2004-N-0188,Reference 3 A Novel Progressive Spongiform Encephalopathy in Cattle re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T16:39:21Z,,0,0,0900006481ecead2
FDA-2004-N-0188-0095,FDA,FDA-2004-N-0188,Reference 29 vCJD Key Facts re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T19:07:31Z,,0,0,0900006481ecec5f
FDA-2004-N-0188-0097,FDA,FDA-2004-N-0188,Reference 31 Report of the OIE Scientific Commission for Animal Diseases re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T19:10:58Z,,0,0,0900006481ecec61
FDA-2004-N-0188-0078,FDA,FDA-2004-N-0188,Reference 14 Long-Term Subclinical Carrier State Precedes Scrapie Replication and Adaptation in a Resistant Species: Analogies to Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease in Humans re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T17:00:27Z,,0,0,0900006481ecec4a
FDA-2004-N-0188-0081,FDA,FDA-2004-N-0188,Reference 12 Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T17:08:54Z,,0,0,0900006481ecef51
FDA-2004-N-0188-0071,FDA,FDA-2004-N-0188,Reference 5 Variant CJD Cases Worldwide re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T16:45:30Z,,0,0,0900006481ecef49
FDA-2004-N-0188-0072,FDA,FDA-2004-N-0188,Reference 6 Recognition of BSE Risk Status of Member Countries -D12483 re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T16:46:55Z,,0,0,0900006481ecef4a
FDA-2004-N-0188-0092,FDA,FDA-2004-N-0188,Reference 25 Scientific Opinion on BSE risk in bovine intestines and mesentery EFSA Panel on Biological Hazards (BIOHAZ) re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T19:00:32Z,,0,0,0900006481ecec5b
FDA-2004-N-0188-0093,FDA,FDA-2004-N-0188,Reference 26 GMIA Gelatin Handbook 2012 re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T19:02:15Z,,0,0,0900006481ecec5c
FDA-2004-N-0188-0080,FDA,FDA-2004-N-0188,Referemce 11 The Sourcing and Processing of Gelatin to Reduce the Potential Risk Posed by Bovine Spongiform Encephalopathy (BSE) in FDA-Regulated Products for Human Use re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T17:06:48Z,,0,0,0900006481ecef50
FDA-2004-N-0188-0086,FDA,FDA-2004-N-0188,Reference 19 BSE Summary Statistics re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T17:19:24Z,,0,0,0900006481ecec50
FDA-2004-N-0188-0077,FDA,FDA-2004-N-0188,Reference 10 Opinion of the Scientific Panel on Biological Hazards of the European Food Safety Authority on the “Quantitative assessment of the human BSE risk posed by gelatine with respect to residual BSE risk” re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T16:57:28Z,,0,0,0900006481ecef4f
FDA-2004-N-0188-0068,FDA,FDA-2004-N-0188,Reference 2 Transmission Dynamics and Epidemiology of BSE in British Cattle re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T16:37:46Z,,0,0,0900006481ecead1
FDA-2004-N-0188-0085,FDA,FDA-2004-N-0188,Reference 18 BSE - An Appraisal of the Current Epidemic in the United Kingdom re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-25T16:40:09Z,,0,0,0900006481ecec4f
FDA-2004-N-0188-0087,FDA,FDA-2004-N-0188,Reference 20 Scientific Opinion on BSE Risk in Bovine Intestines EFSA Panel on Biological Hazards (BIOHAZ) re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T17:21:41Z,,0,0,0900006481ecec51
FDA-2004-N-0188-0096,FDA,FDA-2004-N-0188,Reference 30 WHO Tables On Tissue Infectivity Distribution in Transmissible Spongiform Encephalopathies re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T19:09:39Z,,0,0,0900006481ecec60
FDA-2004-N-0188-0066,FDA,FDA-2004-N-0188,List of References - 2011-902 re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-25T16:33:27Z,,0,0,0900006481eceacf
FDA-2004-N-0188-0084,FDA,FDA-2004-N-0188,"Reference 17 EC, The TSE Roadmap re Use of Materials Derived From Cattle in Human Food and Cosmetics",Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T17:15:04Z,,0,0,0900006481ecec4d
FDA-2004-N-0188-0089,FDA,FDA-2004-N-0188,Reference 22 REPORT ON MEASURES RELATING TO BOVINE SPONGIFORM ENCEPHALOPATHY (BSE) IN THE UNITED STATES re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T17:27:17Z,,0,0,0900006481ecec53
FDA-2004-N-0188-0098,FDA,FDA-2004-N-0188,Reference 32 Prevalent Abnomal Prior Protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T19:12:26Z,,0,0,0900006481ecec62
FDA-2004-N-0188-0082,FDA,FDA-2004-N-0188,Reference 13 Transmission of the BSE Agent to Mice in the Absence of Detectable Abnormal Prion Protein re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T17:10:46Z,,0,0,0900006481ecef52
FDA-2004-N-0188-0075,FDA,FDA-2004-N-0188,Reference 8B Inactivation of the bovine-spongiform-encephalopathy (BSE) agent by the acid and alkaline processes used in the manufacture of bone gelatine re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T16:53:55Z,,0,0,0900006481ecef4d
FDA-2004-N-0188-0094,FDA,FDA-2004-N-0188,Reference 27 An Evaluation of the Risk of Variant Creutzfeldt-Jakob Disease from Exposure to Cattle-Derived Protein Used in Cosmetics re Use of Materials Derived From Cattle in Human Food and Cosmetics,Supporting & Related Material,Background Material,2016-03-18T04:00:00Z,2016,3,,,2016-03-18T19:04:22Z,,0,0,0900006481ecec5d